Pascal Roy

9.0k total citations
207 papers, 3.3k citations indexed

About

Pascal Roy is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Pascal Roy has authored 207 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 39 papers in Pulmonary and Respiratory Medicine and 29 papers in Oncology. Recurrent topics in Pascal Roy's work include Cancer Genomics and Diagnostics (9 papers), Cerebrovascular and Carotid Artery Diseases (9 papers) and Breast Cancer Treatment Studies (7 papers). Pascal Roy is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cerebrovascular and Carotid Artery Diseases (9 papers) and Breast Cancer Treatment Studies (7 papers). Pascal Roy collaborates with scholars based in France, United States and Belgium. Pascal Roy's co-authors include Bertrand Coiffier, Gilles Salles, Carole Charlot, Krzysztof Warzocha, Dominique Rigal, Jacques Bienvenu, Patrícia Miranda Leite Ribeiro, Emmanuelle Dantony, Julien Péron and Marc Buyse and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Pascal Roy

197 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Roy France 29 797 664 574 560 405 207 3.3k
Jean‐Pierre Daurès France 43 1.0k 1.3× 1.2k 1.8× 913 1.6× 1.1k 1.9× 534 1.3× 168 6.8k
Alexander Strasak Austria 39 689 0.9× 850 1.3× 689 1.2× 719 1.3× 591 1.5× 83 4.4k
Erin Moshier United States 41 1.5k 1.8× 971 1.5× 575 1.0× 788 1.4× 633 1.6× 245 6.1k
Mehmet Birhan Yılmaz Türkiye 34 945 1.2× 698 1.1× 650 1.1× 521 0.9× 448 1.1× 346 4.7k
Shai Linn Israel 36 853 1.1× 353 0.5× 443 0.8× 538 1.0× 488 1.2× 128 4.2k
Gabriele Cevenini Italy 34 489 0.6× 509 0.8× 668 1.2× 1.1k 1.9× 712 1.8× 212 4.0k
Colin A. Graham Hong Kong 40 1.5k 1.9× 1.1k 1.7× 968 1.7× 591 1.1× 754 1.9× 367 6.5k
Juan Wang China 31 845 1.1× 397 0.6× 498 0.9× 439 0.8× 593 1.5× 305 3.6k
Toshimitsu Hamasaki Japan 40 1.0k 1.3× 507 0.8× 917 1.6× 404 0.7× 954 2.4× 203 5.1k
Yukio Yuzawa Japan 44 1.1k 1.4× 794 1.2× 590 1.0× 474 0.8× 1.7k 4.3× 199 6.7k

Countries citing papers authored by Pascal Roy

Since Specialization
Citations

This map shows the geographic impact of Pascal Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Roy more than expected).

Fields of papers citing papers by Pascal Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Roy. The network helps show where Pascal Roy may publish in the future.

Co-authorship network of co-authors of Pascal Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Roy. A scholar is included among the top collaborators of Pascal Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Roy. Pascal Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fervers, Béatrice, Thomas Coudon, Delphine Praud, et al.. (2024). Joint effects of long-term exposure to multiple air pollutants and breast cancer risk.. Journal of Clinical Oncology. 42(16_suppl). 10572–10572. 1 indexed citations
3.
Elias, Christelle, Patrick Basset, Frédéric Laurent, et al.. (2022). Protocol for a prospective quasi-experimental study on SARS-CoV-2 transmission during outdoor sports events in France: the COVID-ESO project. BMJ Open. 12(6). e055927–e055927.
4.
Roy, Pascal, Alexandre Bélot, Pierre Quartier, et al.. (2022). Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of Vaccination. Journal of Clinical Medicine. 11(14). 4137–4137. 3 indexed citations
5.
Barow, Ewgenia, Florent Boutitie, Bastian Cheng, et al.. (2021). 24-hour blood pressure variability and treatment effect of intravenous alteplase in acute ischaemic stroke. European Stroke Journal. 6(2). 168–175. 5 indexed citations
6.
Lasolle, Hélène, Mad‐Hélénie Elsensohn, Anne Wierinckx, et al.. (2020). Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis. Acta Neuropathologica Communications. 8(1). 190–190. 27 indexed citations
7.
Bauer, Christian, et al.. (2018). Adding sufentanil to ropivacaine in continuous thoracic paravertebral block fails to improve analgesia after video-assisted thoracic surgery. European Journal of Anaesthesiology. 35(10). 766–773. 9 indexed citations
8.
Péron, Julien, Marc Buyse, Brice Ozenne, Laurent Roche, & Pascal Roy. (2016). An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring. Statistical Methods in Medical Research. 27(4). 1230–1239. 47 indexed citations
9.
Péron, Julien, Pascal Roy, Thierry Conroy, et al.. (2016). An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma. Oncotarget. 7(50). 82953–82960. 21 indexed citations
10.
Péron, Julien, Pascal Roy, Brice Ozenne, Laurent Roche, & Marc Buyse. (2016). The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials. JAMA Oncology. 2(7). 901–901. 41 indexed citations
11.
Péron, Julien, Pascal Roy, Keyue Ding, et al.. (2015). Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer. British Journal of Cancer. 112(6). 971–976. 22 indexed citations
12.
Calender, Alain, et al.. (2014). Lack of correlation of BTNL2 polymorphism and cancer risk in sarcoidosis. BTNL2 and cancer risk in sarcoidosis.. PubMed. 31(2). 136–41. 2 indexed citations
13.
Pachéco, Yves, Alain Calender, Serge Lebecque, et al.. (2014). Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort. European Respiratory Journal. 44(Suppl 58). 1734–1734. 2 indexed citations
14.
Cornu, Catherine, Laurent Remontet, Alain Nicolas, et al.. (2010). A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial. BMC Complementary and Alternative Medicine. 10(1). 29–29. 30 indexed citations
15.
Truntzer, Caroline, Delphine Maucort‐Boulch, & Pascal Roy. (2008). Comparative optimism in models involving both classical clinical and gene expression information. BMC Bioinformatics. 9(1). 434–434. 10 indexed citations
16.
Truntzer, Caroline, et al.. (2007). Importance of data structure in comparing two dimension reduction methods for classification of microarray gene expression data. BMC Bioinformatics. 8(1). 90–90. 9 indexed citations
17.
Roy, Pascal, et al.. (2002). Pratique pharmaceutique en France et au Québec : perspectives d'échanges ?. Journal de Pharmacie Clinique. 21(1). 9–13. 2 indexed citations
18.
Roy, Pascal, et al.. (1998). Le contrôle local de la tumeur primitive. Étape indispensable de la guérison des cancers. Cancer/Radiothérapie. 2(6). 668–671. 1 indexed citations
19.
Hours, Martine, Brigitte Dananché, Joëlle Févotte, et al.. (1994). Bladder cancer and occupational exposures.. Scandinavian Journal of Work Environment & Health. 20(5). 322–330. 33 indexed citations
20.
Basak, Sukla, et al.. (1977). Interaction of abscisic acid & indole acetic acid on transcription.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(2). 147–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026